Results 211 to 216 of about 90,572 (216)
Some of the next articles are maybe not open access.
, 2008
The randomized, open-label, phase III trial HOVON-65/GMMG-HD4 was designed to evaluate the efficacy of bortezomib prior to HDM for response and progression-free survival (PFS) in patients with newly diagnosed MM.
P. Sonneveld+23 more
semanticscholar +1 more source
The randomized, open-label, phase III trial HOVON-65/GMMG-HD4 was designed to evaluate the efficacy of bortezomib prior to HDM for response and progression-free survival (PFS) in patients with newly diagnosed MM.
P. Sonneveld+23 more
semanticscholar +1 more source
, 2006
Since 2003, 204 patients (pts) younger than 66 yrs with untreated active MM were randomly assigned to receive a 4 month treatment with Dex/Thal (n=100) or with a VAD-like regimen (n=104).
M. Macro+12 more
semanticscholar +1 more source
Since 2003, 204 patients (pts) younger than 66 yrs with untreated active MM were randomly assigned to receive a 4 month treatment with Dex/Thal (n=100) or with a VAD-like regimen (n=104).
M. Macro+12 more
semanticscholar +1 more source
Contemporary Management Strategies in VAD Infection
Current Heart Failure Reports, 2020Varun K. Phadke, S. Pouch
semanticscholar +1 more source
A modular computational circulatory model applicable to VAD testing and training
Journal of Artificial Organs, 2012G. Ferrari+7 more
semanticscholar +1 more source
Plasma proteomic profiles predict future dementia in healthy adults.
Nature AgingYu Guo+10 more
semanticscholar +1 more source
Vitamin A Deficiency (VAD) After a Duodenal Switch Procedure: a Case Report
Obesity Surgery, 2010C. Stroh+5 more
semanticscholar +1 more source